Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 4 - The Real Truth

Tickford fined for Bathurst buggy breach

Supercars stewards have fined Tickford Racing and enduro driver Zak Best for a golf buggy breach at Bathurst.

Betters Medical Looks Ailing Going Into Hong Kong IPO

Betters Medical Looks Ailing Going Into Hong Kong IPO

Key Takeaways: Betters Medical has launched a Hong Kong listing, relying on high-margin microwave ablation needles as its major revenue contributor The company could face liability of tens of millions of yuan for failing to meet terms of an agreement with one of the investors in its Series C funding…

Jordan Spieth: What’s In The Bag? 2025 Update

Jordan Spieth: What’s In The Bag? 2025 Update

Jordan Spieth once again has the chance to complete the career Grand Slam in 2025. Let's take a look at the clubs he will be using to attempt it...

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

FES International hunts for fourth base on back of record £26m order book

The business, which is marking 25 years of trading, says investment in R&D is now leading to more global contract wins

Birmingham Post

Leftovers pile up for year-end tax bill menu

WASHINGTON — Incentives for clean energy and a tax break for companies’ research and development appear to be off the table for legislation moving this summer, raising the stakes for a potential year-end tax bill after the dust settles on the midterm elections.

Tribune News Service

Leftovers pile up for year-end tax bill menu - Roll Call

Incentives for clean energy and research and development could move as part of a year-end tax bill when the dust settles after the midterms

Gadgets: Limelight for video calls available on Realme Pad X's 5G version

According to GSM Arena, the R&D team has also created a function to make video chats a little bit simpler using the tablet's 105-degree front-facing camera, so that won't be the only change. Full story on Dynamite News:

inkl

Read news from The Economist, FT, and more,
with one subscription

Less talk, more action needed to reform IP for all

IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?

Cognition Therapeutics Begins Mid-Stage Study Of Neurological Disorder Candidate

Cognition Therapeutics Begins Mid-Stage Study Of Neurological Disorder Candidate

Cognition Therapeutics (NASDAQ: CGTX) dosed first patient in the SHIMMER study of lead drug CT1812, an experimental, orally delivered small molecule therapeutic intended to address the underlying biology of dementia with Lewy bodies (DLB).

Abbott Laboratories vs. Edwards Lifesciences: Which Medical Device Stock is a Better Investment?

Abbott Laboratories vs. Edwards Lifesciences: Which Medical Device Stock is a Better Investment?

The growing prevalence of chronic diseases, an increasing elderly population, and rapid adoption of advanced medical technologies are driving the growth of the medical device industry. The industry is expected to witness solid growth over the long term, to the benefit of the stocks of medical device companies Abbott (ABT)…

Lessons learned from an analyst’s journey into COVID-Zero China

Wenting Shen usually travels to China annually as part of her job as an analyst and portfolio manager at investment company Harding Loevner, but the country’s strict “COVID Zero” policies and this year’s Winter Olympics in Beijing made it almost impossible to book a flight.

Tribune News Service

After Rising to Fame as Hot Audio Social App, Yalla Finds New Role Model in Facebook

After Rising to Fame as Hot Audio Social App, Yalla Finds New Role Model in Facebook

Key Takeaways: Yalla said its first-quarter revenue rose 6.9% to a record $72.3 million, as strong gains for its game services offset a first-time decline for its core voice business Company is launching a wide array of new initiatives, including an instant messaging app and its first-ever hardcore game, in…

Edinburgh local looking for love on ITV's Romeo and Duet dating show shares all

Edinburgh local looking for love on ITV's Romeo and Duet dating show shares all

Romeo and Duet contestant Jamie, from Edinburgh, is looking to find love "with a pinch of salt" on former Strictly star Oti Mabuse's ITV dating show, airing on Saturday nights.

Republicans split on adding semiconductor tax breaks to competition bill

Republicans split on adding semiconductor tax breaks to competition bill

An effort to add bipartisan tax incentives for U.S. semiconductor manufacturing to a House bill is running into GOP divisions.

Get all your
news in one place.

100's of premium titles.
One news app.

Caladrius Biosciences To Merge With Privately-Held Cend Therapeutics

Caladrius Biosciences Inc (NASDAQ:CLBS) and privately-held Cend Therapeutics Inc have agreed to merge in an all-stock approximate "merger of equals" transaction approved by the Boards of Directors of each company. The transaction values each company at $90 million, which for Caladrius represents a 136% premium to its market cap on April 26. Following closing, the…

GT300-rules cars slowed for Okayama SUPER GT opener

SUPER GT's GT300-rules cars have been slowed in relation to their FIA GT3 rivals according to the Balance of Performance for next weekend's Okayama season opener.

Yes, the Stock Market Just Went Into Free Fall—It’s Not the Metric You Should Worry About.

The Dow dropped a record 1,175 points yesterday. Don’t worry. A better gauge of the future is going up.

1 2 3 4

People

Mangeet Kaur BounsMangeet

Charles E Grassley

Debbie Stabenow

Benjamin L Cardin

Michael D Crapo

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Republican Party

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

415,731 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play